How to buy cabozantinib in the country?

Cabozantinib is an oral targeted therapy drug mainly used to treat malignant tumors such as renal cell carcinoma (RCC), thyroid cancer and liver cancer. It is a multi-target inhibitor that inhibits tumor growth and spread by simultaneously inhibiting the activity of multiple receptor kinases.

Because cabozantinib is not currently on the market in China, patients cannot purchase the drug directly in China. However, cabozantinib can be purchased through overseas channels, including both original and generic drugs. Original drugs are usually more expensive. For example, the price of original drugs in Japan and Europe is around 30,000 to 40,000 yuan. The price of generic drugs is relatively close to the people. For example, the price of generic drugs in Laos, India, Bangladesh and other places only ranges from a few hundred to several thousand yuan. It is worth mentioning that the ingredients of these original drugs and generic drugs are basically the same, so patients can choose the right drug according to their own conditions.

The mechanism of action of cabozantinib involves the inhibition of multiple receptor kinases, including vascular endothelial growth factor receptor (VEGFR), tumor microenvironment factor receptor (MET) and stem cell factor receptor (CSF-1R). These receptors play important roles in processes such as tumor angiogenesis, tumor cell proliferation, migration and metastasis, and the formation of the tumor microenvironment. By inhibiting the activity of these receptors, cabozantinib interferes with tumor growth and progression, thereby extending patient survival.

In clinical trials, cabozantinib has proven to have certain curative effects on a variety of malignant tumors such as renal cell carcinoma, thyroid cancer, and liver cancer. It is often used as a first-line or later-line treatment option, especially for patients with tumors that have progressed to advanced or metastatic disease. Cabozantinib is generally better tolerated and has fewer toxic side effects than traditional chemotherapy drugs, making it one of the important options for treating these tumors.

However, like other anti-tumor drugs, cabozantinib may also cause some adverse reactions, including hypertension, hand-foot syndrome, proteinuria, fatigue and gastrointestinal discomfort. Therefore, when using cabozantinib, doctors will monitor and manage the patient on a case-by-case basis to ensure the safety and effectiveness of the treatment.